3-Bromo-6-methylimidazo[1,2-a]pyridine is a brominated heterocyclic compound used as a pharmaceutical intermediate. It is structurally related to the 5-HT4 receptor partial agonist CJ-033466.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 3-bromo-6-methylimidazo[1,2-a]pyridine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
5-Chloro-7-azaindole
pharmaceutical intermediate
Ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate
pharmaceutical intermediate
1-[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]-N-methylmethanamine
pharmaceutical intermediate
2,2,2-Trifluoro-1-(piperidin-4-yl)ethan-1-one
pharmaceutical intermediate
3-bromo-6-methylimidazo[1,2-a]pyridine
MMZMYJJVBJHMLU-UHFFFAOYSA-N
CC1=CN2C(=NC=C2Br)C=C1
—
Sourcing 3-bromo-6-methylimidazo[1,2-a]pyridine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.